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Abstract
Background: Pseudo-Mahaim (AP-M) fibers are a rare variant of atrioventricular (AV)
accessory pathways. Atriofascicular and atrioventricular accessory connections are
characterized by slow conduction and decremental properties. Dual physiological AV node
pathways, slow and fast, are observed in a large number of patients with AP-M. Therefore,
there is substrate for AV nodal reentrant tachycardia (AVNRT) in addition to antidromic AV
reentrant tachycardia (AVRT) with left bundle branch block (LBBB)-like morphology. Other
arrhythmia such as atrial fibrillation (AF) or atrial flutter (AFL) and ventricular fibrillation
(VF) are also observed. We analysed the occurrence of arrhythmias in a group of patients with
AP-M treated in our department.
Methods: We evaluated 27 patients (12 women) aged 14–53 years (mean age 25.6 years)
with AP-M. The clinical course in these patients, in particular with regard to the occurrence of
arrhythmias, was analysed. Patients with dual AV node properties were compared to patients
without such findings.
Results: We found dual AV node properties in 18 patients (Group 1), while 9 patients had
fast pathway only (Group 2). Twenty-six patients presented with AVRT, 2 patients with
AVNRT, 3 patients with AF, 1 patient with AT, 2 patients with AFL, and 3 patients with VF.
In 2 patients, AP-M were seen in an atypical area. In one patient, the pathway connected the
right atrium with the left ventricle (septal region), and in the other patient it connected the left
atrium with the left ventricle (left anterior region).
Conclusions: The majority of AP-M was right-sided. Two thirds of patients with AP-M had
anatomical substrate for AVNRT (fast/slow pathway AV node). VF or asystole occurred in
10% of patients. (Cardiol J 2008; 15: 365–370)
Key words: pseudo-Mahaim fibers, atriofascicular pathway, radiofrequency
catheter ablation
Introduction
Atrioventricular (AV) pathways characterized
by slow antegrade conduction comprise less than
3% of all accessory pathways [1]. These are called
pseudo-Mahaim fibers (AP-M) and include atrio-
fascicular pathways connecting the atrium with the
right His bundle branch and AV pathways connec-
ting the atrium with the ventricular muscle [2–4].
These pathways are most commonly right-sided
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and located within the free wall (of the atrium and
ventricle), less frequently within the septum, and
very rarely they are left-sided [5]. During sinus
rhythm, preexcitation is absent or mild [6]. This
anomaly predisposes to episodes of antidromic AV
reentrant tachycardia (AVRTa) with left bundle
branch block (LBBB)-like morphology and retro-
grade atrial activation through the physiologic His-
Purkinje system and the fast pathway within the
AV node (AVN) or through another “fast” acces-
sory pathway (AP) conducting in a retrograde di-
rection [1, 7]. Radiofrequency (RF) current abla-
tion may be performed within both proximal and
distal part of the pathway [8–10].
Episodes of antidromic tachycardia are often
accompanied by other arrhythmia such as AV node
reentrant tachycardia (AVNRT), atrial fibrillation
(AF), atrial tachycardia (AT), atrial flutter (AFL),
and ventricular fibrillation (VF) [11].
Methods
We analyzed the clinical course and risk in 27
patients aged 14–53 years (mean age 25.6 years),
including 12 women, who were evaluated and tre-
ated for recurrent arrhythmia in the Institute of
Cardiology, Warszawa-Anin, and were found to
have AP-M during the electrophysiologic study
(EPS).
The patients were divided in two groups ba-
sed on the presence of AVN pathways, slow and
fast, as found during EPS. Group 1 included pa-
tients without slow pathway within AVN (Table 1),
and Group 2 included patients with both slow and
fast pathways within AVN (Table 2). We evaluated
whether the presence of dual AVN properties af-
fected the analyzed parameters.
We analyzed data from:
— history and physical examination in regard to
arrhythmia and coexisting conditions, and in
particular the occurrence of AVRT, AVNRT,
AT, AF, and VF;
— laboratory testing (12-lead ECG during si-
nus rhythm and arrhythmia, standard Hol-
ter monitoring, exercise test, and echocar-
diography);
— EPS before and after RF ablation, including data
regarding the RF ablation procedure itself.
One or combination of the following electrophy-
siologic characteristics of AP-M were found [12–14]:
— slow antegrade conduction with decrement, or
increase in AV conduction time by more than
30 ms with progressively faster pacing rate;
— the presence of activation signal [high frequ-
ency spike (M)] along the pathway;
— the ability to induce conduction block within
the pathway by mechanical pressure (e.g. com-
pression using electrode);
— the absence of retrograde conduction through
the AP during EPS;
— automaticity (both spontaneous and evoked,
e.g. by application of RF current).
The two subgroups were compared in regard
to the evaluated parameters using both parame-
tric and nonparametric tests (Fisher test, Wilco-
xon test).
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Results
The accessory pathways were right-sided in
25 patients. In one patient, the ventricular end of
Table 1. Group 1: patients without dual AVN properties.
No. Gender Age Arrhythmia Disease Treatment
1 M 18 AVRTa RF
2 F 34 AVRTa, VF RF
3 F 23 AVRTa S Æ RF
4 M 18 AVRTa MVP RF
5 M 23 AVRTa RF
6 M 30 AT* RF
7 M 53 AVRTa, AF, AFL ASD RF
8 F 27 AVRTa RF
9 F 32 AVRTa S Æ RF
28,7
AVRTa — antidromic atrioventricular reentrant tachycardia; AT — atrial tachycardia (*with no retrograde conduction in EP study); AF — atrial fibrilla-
tion; AFL — atrial flutter; VF — ventricular fibrillation; MVP — mitral valve prolapse; ASD — atrial septal defect; S — surgery, RF — radiofrequency
current ablation
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AP (M signal) was ablated on the left side of the
interventricular septum. In another patient, AP
was connecting the left atrium with the upper part
of the left ventricle. The precise localization of
APs in patients in both subgroups is depicted in
Figure 1.
None of the evaluated parameters reached sta-
tistical significance (Table 3).
Overall, AVN show slow antegrade conduc-
tion in two thirds of patients. In this subset (Gro-
up 2), spontaneous AVNRT was noted in 2 pa-
tients (11.1%), but was induced during EPS in 10
patients (55.6%). RF ablation of the slow pathway
within AVN was not performed in patients in
whom sustained AVNRT was not induced during
EPS.
In one patient in Group 1 (with several dozens
of arrhythmia episodes per year, the longest la-
sting for approx. 70 h), an episode of AVRTa de-
generated into VF. In one patient in Group 2, VF
occurred following an attempt of electrical cardio-
version (AVRTa Æ intravenous amiodarone Æ
AVRTa Æ electrical cardioversion Æ VF), and ano-
ther patient (with a history of AVRTa episodes and
syncope) suffered cardiac arrest with VF detected
during resuscitation. Notably, asystole seen in 3
cases was related to various antiarrhythmic drug
therapy during attempts to restore sinus rhythm
in two of these patients.
Table 2. Group 2: patients with dual AVN properties.
No. Gender Age Arrhythmia Disease Treatment
1 M 39 AVRTa RF
2 M 19 AVRTa RF
3 M 18 AVRTa RF
4 M 22 AVRTa RF
5 F 19 AVRTa RF
6 F 23 AVRTa MVP RF
7 F 25 AVRTa MVP RF
8 M 19 AVRTa RF
9 M 14 AVRTa Mild TI RF
10 F 20 AVRTa RF
11 M 19 AVRTa MVP RF
12 F 46 AVRTa, AVNRT RF
13 M 40 AVRTa, VT* S Æ RF
14 F 17 AVRTa MVP RF
15 M 17 AVRTa, AVNRT, AF, AFL, VF RF
16 F 26 AVRTa, VF MVP, PFO RF
17 F 16 AVRTa RF
18 M 34 AVRTa, AF RF
24,1
AVNRT — atrioventricular node reentrant tachycardia; TI — tricuspid insufficiency; PFO — patent foramen ovale; VT — ventricular tachycardia
(*focal — originating from the left ventricle); remaining abbreviation as in Table 1
In Group 1, three out of 9 patients underwent
one ablation procedure (surgical or RF) prior to the
successful RF ablation, and in Group 2 seven out of
18 patients underwent 1 to 5 (!) such procedures in
various centers.
Figure 1 Schematic representation of the atrioventricu-
lar valve anuli and the coronary sinus with localization
of AP-M. Data indicate the number of patients with AP
in a given location in Group 1/Group 2. TV — tricuspid
valve; MV — mitral valve; CS — coronary sinus. Acces-
sory pathways: RS — right-sided superior; RA-S — ri-
ght-sided anterosuperior; RA — right-sided anterior;
RA-I — right-sided anteroinferior; RI — right-sided infe-
rior; S — septal (*one of the septal pathways had the
ventricular end on the left side of the interventricular sep-
tum); CS — coronary sinus; LS — left-sided superior.
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Table 3. Results — overall and in the two groups.
Patient characteristics Overall Group 1 Group 2 p
Number of patients 27 9 18
Women 12 (44.4%) 4 (44.4%) 8 (44.4%) NS
Mean age ± SD 25.6 ± 9.9 28.7 ± 10 24.1 ± 9 NS
AVRTa 26 (96.3%) 8 (88.9%) 18 (100%) NS
Mean heart rate ± SD 196.3 ± 25 200 ± 18 195.3 ± 26 NS
during AVRTa
AVNRT 2 (7.69%) 0 (0%) 2 (11.11%) NS
AF 3 (11.11%) 1 (11.11%) 2 (11.11%) NS
AT 1 (3.7%) 1 (11.11%) 0 (0%) NS
AFL 2 (7.41%) 1 (11.11%) 1 (5.56%) NS
VF 3 (11.11%) 1 (11.11%) 2 (11.11%) NS
Asystole during 3 (11.11%) 2 (22.22%) 1 (5.56%) NS
antiarrhythmic treatment
Syncope (except VF and asystole) 6 (22.22%) 3 (33.33%) 3 (16.67%) NS
Near-syncope 12 (44.44%) 2 (22.22%) 10 (55.56%) NS
Structural heart disease 8 (29.63%) 2 (22.22%) 6 (33.33%) NS
Number of procedures (S and RF) 16 3 13 NS
prior to successful ablation
Abbreviation as in Table 1
Discussion
Pseudo-Mahaim fibers, except in very rare ca-
ses, are right-sided pathways. Most of their elec-
trophysiologic characteristics suggest that these
are an equivalent (replica) of the physiological con-
duction system, or essentially second (and in sin-
gle reported cases the only one), right-sided AVN
with a (right) His bundle branch [3, 4, 7, 10, 12].
We demonstrated the presence of a slow path-
way within AVN in most (2/3) patients in our study,
which is consistent with findings of other authors. In-
terestingly, only a few patients experienced sponta-
neous AVNRT (2 patients), while during EPS this ar-
rhythmia was induced in 10 patients (56%). Perhaps
AVNRT in fact occurs more commonly than it is dia-
gnosed and/or documented in ECG. This underrating
might result from a number of causes. One reason
might be that in the presence of AP-M, AVNRT mi-
ght be conducted to ventricles through the accessory
pathway (bystander) and thus would be difficult to
distinguish from AVRTa, as both arrhythmias present
with wide QRS complexes with LBBB-like morpho-
logy (Fig. 2). AVNRT might also convert into AVRTa
or AF/AFL (Fig. 3) [11]. Finally, AVNRT might have
also been less common due to a relatively young age
of our patients (mean 25.6 years).
Low number of patients in both groups, resul-
ting from rarity of these phenomena, does not al-
low definite conclusions to be made, but our findings
suggest that no significant differences in the clini-
cal course exist between patients with AP-M and
either fast pathway only or both slow and fast path-
ways within AVN. The qualitative difference, i.e. the
occurrence of AVNRT, has been already mentioned.
A direct life-threatening situation in all these
patients is VF. This arrhythmia occurs with a fre-
quency similar to that in patients with Wolff-Parkin-
son-White syndrome and AVRT. Asystole seen in
3 patients may be related to physician doubts regar-
ding the diagnosis of AVRT and VT. In case of such
doubts, the arrhythmia was treated more aggressi-
vely, often with several antiarrhythmic drugs. Also
of note, patients with AP-M often underwent many
unsuccessful ablation procedures before referral.
This is due to a low prevalence of this condition and
thus small experience of electrophysiologists in this
regard, but also from a relative difficulty of perfor-
ming ablation of AP-M.
Patients with AP-M (“dual AVN”) present with
various kinds of arrhythmia, with AP-M being an ele-
ment of a macro-reentry circuit or a bystander. Par-
ticular electrophysiologic characteristics of this con-
dition result in difficulties related to diagnosis and
treatment. For some years, electrophysiologic cha-
racteristics of the “Mahaim syndrome” was interpre-
ted in a concordant but wrong way even by the most
renowned electrophysiologists. Even now, when it
seems we finally know how to interpret these phe-
nomena correctly, repeated ablation procedures are
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necessary more frequently than in other clinical syn-
dromes related to the presence of APs.
Conclusions
Accessory AV pathways with slow antegrade
conduction are mostly right-sided (92.6%), but the-
se may also be located on the left side.
Two thirds of patients with AP-M had anato-
mical substrate for AVNRT — dual AV node pro-
perties with fast and slow pathways.
Life-threatening events, such as VF and asystole,
were seen in more than 10% of patients with AP-M.
Definitive antiarrhythmic treatment in these
patients required, on average, performing 1,6 abla-
tion procedures (surgical or RF).
The analyzed groups did not differ with regard
to the clinical course of spontaneously occurring
arrhythmia.
Acknowledgements
The authors appreciate help of dr Piotr Jędru-
sik with preparation of the authorized English ver-
sion of the manuscript.
The authors do not report any conflict of inte-
rest regarding this work.
Figure 3. AVNRT (first 3 QRS complexes) conducted
through physiological pathways (normal width QRS
complexes, a visible His bundle signal — solid arrow,
the atrial signal hidden within the QRS complex — da-
shed arrow) gradually converts into antidromic AVRT in
subsequent beats (the His bundle signal becomes hid-
den within the QRS complex, and the atrial signal fol-
lows QRS complexes — dashed arrow).
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Figure 2. Pseudo-Mahaim fibers as a bystander. A. AVNRT conducted to ventricles through Mahaim fibers (first and
second QRS complex, whereby no His bundle signal is seen) and a fusion beat with impulse conducted both through
Mahaim fibers and AVN (third QRS complex with visible His bundle signal — solid arrow). The atrial signal is hidden
within the QRS complex (dashed arrow). B. Antidromic AVRT. The His bundle signal follows the ventricular signal
(solid arrow), and the atrial signal is seen even later after the QRS complex (dashed arrow).
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